Three Russian pharmaceutical companies are negotiating the supply and localization of their drugs in Saudi Arabia, Russian Minister of Industry and Trade Anton Alikhanov told journalists at the Innoprom. Saudi Arabia exhibition.
“There are a number of our initiatives related to the pharmaceutical market. Three of our companies are already in negotiations with Saudi partners not only about drug registration and direct supplies from Russia to the Saudi market but also on localization matters, particularly regarding insulins,” said the minister. He did not specify the names of the companies.
It was previously reported that pharmaceutical representatives would participate in Moscow’s exposition at Innoprom. Saudi Arabia. Among the 10 capital companies mentioned were manufacturers of pharmaceutical substances and medical devices, including the company Elta, which produces portable glucometers and consumables, and the Zelenograd Research Institute of Molecular Electronics (NIIME), a developer of microelectronics and medical technologies, including microcontrollers and electromyographic sensors. Furthermore, the Vladimir-based drug manufacturer Generium is also on the list of exhibition participants.
